Stay updated on Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Sign up to get notified when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.

Latest updates to the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNo substantive changes to core study content were detected; observed differences seem limited to formatting and layout adjustments that do not alter the information shown. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check32 days agoChange DetectedMajor change: version updated to v3.2.0 and a government operating status notice added. Previous v3.1.0 revision tag removed.SummaryDifference3%

- Check40 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check54 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed. No other substantive changes detected.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various medical topics related to head and neck cancer and associated treatments. Notably, the revision number has been updated to v3.0.0.SummaryDifference4%

Stay in the know with updates to Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.